Anthony Lauder, MD
Hand Surgery · Longview, WANPI 1316990088
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 74.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $9,825 and has fallen 98.9% since, to $112 in 2025. Among hand surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $357.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$14K
- Steelhead Surgical Inc$5K
- Stryker$107
- Bioventus LLC$33
- Left Coast Surgical Inc$26
- DJO, LLC$15
What the payments were for
- Speaking & faculty fees$10,00053%
- Travel & lodging$2,95116%
- Food & beverage$1,1416%
- Education$4,84726%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 33 | $14,074 |
| Steelhead Surgical Inc | 13 | $4,685 |
| Stryker | 3 | $107 |
| Bioventus LLC | 2 | $33 |
| Left Coast Surgical Inc | 1 | $26 |
| DJO, LLC | 1 | $15 |
How this compares
$18,939 in reported general payments places this provider in the 90th percentile of 75 hand surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 115 | $547 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 88 | $465 |
| Tramadol Hcl | 77 | $238 |
| Ondansetron OdtOndansetron | 11 | $95 |
| Hydromorphone Hcl | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Longview
- Thomas TrumbleBellevue$824K
- Jerry HuangSeattle$428K
- Mary ThayerBellevue$51K
- Chelsea BoeSeattle$32K
- Julie RobertsFederal Way$19K
- Gregory ByrdOlympia$17K
- Chad TurnerSpokane Valley$17K
- Benjamin JacobsVancouver$16K
- Marijke DevosSilverdale$15K
- Jillian McLaughlinEverett$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.